Showing results (91-100 of 759) with videos related to
Sort By:
Pageof 76
Cancer Research|July 25, 2006
Proteasome inhibitor drugs on the riseClaudio A P Joazeiro, Kenneth C Anderson, Tony HunterBest Practice & Research. Clinical Haematology|July 20, 2005
Cytokines and signal transductionTeru Hideshima, Klaus Podar, Dharminder Chauhan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2022
Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor ResponseShih-Feng Cho, Kenneth C Anderson, Yu-Tzu TaiJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Identification and validation of novel therapeutic targets for multiple myelomaTeru Hideshima, Dharminder Chauhan, Paul Richardson, et al.Medical Oncology (Northwood, London, England)|February 20, 2010
The evolution and impact of therapy in multiple myelomaJacob P Laubach, Paul G Richardson, Kenneth C AndersonHematology/Oncology Clinics of North America|November 13, 2007
Mouse models of human myelomaConstantine S Mitsiades, Kenneth C Anderson, Daniel R CarrascoFrontiers in Immunology|August 28, 2018
Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based ImmunotherapyShih-Feng Cho, Kenneth C Anderson, Yu-Tzu TaiExpert Opinion on Therapeutic Targets|June 7, 2005
Targeting signalling pathways for the treatment of multiple myelomaKlaus Podar, Teru Hideshima, Dharminder Chauhan, et al.Blood Reviews|August 7, 2002
Novel therapies for multiple myelomaJoan J Ryoo, Craig Emmitt Cole, Kenneth C AndersonFrontiers in Immunology|August 28, 2018
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1Yu-Tzu Tai, Shih-Feng Cho, Kenneth C AndersonPageof 76